Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Polypills Added to List of WHO’s Essential Medicines

News Daily News

Polypills Added to List of WHO’s Essential Medicines

Michael O'Riordan

August 02, 2023

Polypill Bests Usual Care in Patients With Recent MI: SECURE

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

October 26, 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

News Conference News TCT 2020

Delays, Deaths, and More Cardiogenic Shock Among ACS Patients With COVID-19

October 14, 2020

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

News Daily News

Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients

Michael O'Riordan

October 17, 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

News Conference News ACC 2019

Modest LDL Cholesterol Reduction With Bempedoic Acid in Among High-Risk Patients: CLEAR Wisdom

Michael O'Riordan

March 20, 2019

News Daily News

Más Quelación: Se Aprueba el Ensayo TACT2 para el Controvertido Tratamiento Post-IM en Pacientes Diabéticos

September 28, 2016

News Daily News

冠脉内阿昔单抗显示对糖尿病 STEMI 患者有优势

August 11, 2016

News Daily News

Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients

August 11, 2016

News Daily News

El Abciximab Intracoronario es Beneficioso en Pacientes Diabéticos Víctimas de STEMI

August 11, 2016

News Conference News ACC 2015

Long-Term DAPT with Ticagrelor Reduces Ischemic Risk, Ups Bleeding in MI Patients

March 14, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.